Karen Drexler Biography and Net Worth

Director of Outset Medical

Karen is a healthcare industry veteran with a focus on chronic disease management, data analytics, and home based care. She has been an active board member for public and private medical device and diagnostics companies for over a decade. She currently sits on the boards of ResMed (NYSE:RSMD), EBR Systems (ASX:EBR), VIDA Diagnostics, and Huma.AI, and formerly served on the board of Tivic Health Systems (NASDAQ:TIVC). Most recently, she was CEO of Sandstone Diagnostics, a life science tools company focused on increased access to high-quality diagnostic testing. Previously, she founded and served as CEO at Amira Medical until its sale to Roche Diabetes Care. She started her career at LifeScan, where she managed a variety of functions and ultimately executed the sale of the company to Johnson & Johnson.

What is Karen Drexler's net worth?: The estimated net worth of Karen Drexler is at least $33.33 thousand as of December 1st, 2025. Ms. Drexler owns 10,650 shares of Outset Medical stock worth more than $33,335 as of September 23rd. This net worth approximation does not reflect any other assets that Ms. Drexler may own. Learn More about Karen Drexler's net worth.
How do I contact Karen Drexler?: The corporate mailing address for Ms. Drexler and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on Karen Drexler's contact information.
Has Karen Drexler been buying or selling shares of Outset Medical?: Karen Drexler has not been actively trading shares of Outset Medical during the past quarter. Most recently, Karen Drexler sold 1,548 shares of the business's stock in a transaction on Monday, December 1st. The shares were sold at an average price of $4.37, for a transaction totalling $6,764.76. Following the completion of the sale, the director now directly owns 10,650 shares of the company's stock, valued at $46,540.50. Learn More on Karen Drexler's trading history.
Who are Outset Medical's active insiders?: Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), Karen Drexler (Director), D. Grossman (Director), James Hinrichs (Director), Marc Nash (SVP), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.
Are insiders buying or selling shares of Outset Medical?: In the last year, insiders at the sold shares 23 times. They sold a total of 79,958 shares worth more than $369,186.67. The most recent insider tranaction occured on August, 17th when General Counsel John L. Brottem sold 2,632 shares worth more than $11,554.48. Insiders at Outset Medical own 2.5% of the company. Learn More about insider trades at Outset Medical.
Information on this page was last updated on 8/17/2026.

Karen Drexler Insider Trading History at Outset Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/1/2025	Sell	1,548	$4.37	$6,764.76	10,650

Karen Drexler Buying and Selling Activity at Outset Medical

Outset Medical Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Today's Range

Now: $3.11

$3.12

$3.25

50 Day Range

MA: $4.09

$3.10

$5.22

2 Week Range

Now: $3.11

$3.00

$16.16

Volume

54,012 shs

Average Volume

368,613 shs

Market Capitalization

$58.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9